Quantifying Hepatic Mitochondrial Fluxes in Humans

NCT05305287 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Non-Alcoholic Fatty Liver Disease
Type 2 Diabetes
Mitochondrial Metabolism Disorders

Interventions

DRUG: Pioglitazone
OTHER: Placebo

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

[object Object]